DRTS
Alpha Tau Medical Ltd
NASDAQ: DRTS · HEALTHCARE · BIOTECHNOLOGY
$7.37
+0.96% today
Updated 2026-04-29
Market cap
$712.00M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.53
Dividend yield
—
52W range
$3 – $9
Volume
0.3M
Alpha Tau Medical Ltd (DRTS) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | $31.56M | $52.99M | $42.22M | $120.15M | $107.39M | $86.20M |
| Cash & equivalents | $1.83M | $15.60M | $23.24M | $5.84M | $12.66M | $13.72M |
| Current assets | $29.83M | $47.45M | $32.64M | $106.48M | $85.76M | $64.23M |
| Total liabilities | $31.75M | $61.42M | $76.99M | $14.49M | $22.91M | $23.54M |
| Current liabilities | $1.35M | $2.09M | $4.41M | $4.34M | $7.10M | $8.68M |
| Long-term debt | — | — | — | — | $5.61M | $5.56M |
| Shareholder equity | $-193000.00 | $-8.43M | $-34.78M | $105.66M | $84.47M | $62.67M |
| Retained earnings | $-16.69M | $-25.57M | $-52.84M | $-86.60M | $-115.76M | $-147.51M |
| Accounts receivable | $141000.00 | $477000.00 | $480000.00 | $32000.00 | $19000.00 | $332000.00 |
| Inventory | $1.13M | $-29.85M | $-8.17M | $-1.06M | $-19000.00 | — |
| Goodwill | — | — | — | — | — | — |